Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: Studies in the fasting and postprandial states: The European Atherosclerosis Research Studies

Circulation

Volumn 96, Issue 3, 1997, Pages 733-740

  Gerdes, Christian ^a   Fisher, Rachel M ^b   Nicaud, Viviane ^c   Boer, Jolanda ^c   Humphries, Steve E ^b   Talmud, Philippa J ^b   Faergeman, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

EARS Group; Epidemiology; Genetics; Obesity; Postprandial lipemia

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DNA DETERMINATION; EUROPE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENOTYPE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROGENY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030752544     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.733     Document Type: Article

References (31)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
2. Sprecher DL, Feigelson HS, Laskazewski PM. The low HDL cholesterol/high triglyceride trait. Arterioscler Thromb. 1993;13: 495-504.
3. 2: relations of the plasma level of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 1987;80:341-347.
4. Sprecher DL, Hein MJ, Laskarzewski PM. Conjoint high triglycerides and low HDL cholesterol across generations. Circulation. 1994; 90:1177-1184.
5. Humphries SE. DNA polymorphisms of the apolipoprotein genes: their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis. 1988;72:89-108.
6. Gerdes C, Gerdes LU, Hansen PS, Faergeman O. Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation. 1995; 92:1765-1769.
7. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud PJ. A common variant in the gene for lipoprotein lipase (Asp9-Asn). Arterioscler Thromb Vasc Biol. 1995;15:468-478.
8. Reymer PWA, Gagné E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Lie KE, Kastelein JJ, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet. 1995;10:28-34.
9. Patsch JR, Prasad S, Gotto AM Jr, Bengtsson-Olivecrona G. Post-prandial lipemia: a key for the conversion of high density lipoproteins by hepatic lipase. J Clin Invest. 1984;74:2017-2023.
10. Patsch JR, Miesenböck G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. Relation of triglyceride metabolism and coronary heart disease. Arterioscler Thromb. 1992; 12:1336-1345.
11. Pimstone SN, Clee SM, Gagne SE, Miao L, Zhang HF, Stein EA, Hayden MR. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res. 1996;37:1675-1684.
12. Tiret L, Nicaud V, Ehnholm C, Havekes L, Menzel HJ, Ducimetière P, Cambien F. Inference of the strength of genotype-disease association from studies comparing offspring with and without parental history of disease. Ann Hum Genet. 1993;57: 141-149.
13. The EARS Group. The European Atherosclerosis Research Study (EARS): design and objectives. Int J Epidemiol. 1994;23: 465-471.
14. The EARS Group. The distribution of fasting plasma lipid concentrations in the offspring of men with premature coronary heart disease in Europe: the EARS Study. Int J Epidemiol. 1994;23: 472-481.
15. Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F, De Backer G. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects: the EARS Study. Circulation. 1994; 89:167-173.
16. Whittall R, Gudnason V, Weavind GP, Day LB, Humphries SE, Day INM. Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolemia for mutations in exon 3 of the low density lipoprotein receptor gene. J Med Genet. 1995;32: 509-515.
17. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ. Interaction of the lipoprotein lipase asparagine 291-serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res. 1995; 36:2104-2112.
18. Packard CJ, Shepherd J. Current concepts in the treatment of familial hypercholesterolaemia. Curr Opin Lipidol. 1995;6:57-61.
19. Humphries SE. Life style, genetic factors and the risk of heart attack: the apolipoprotein B gene as an example. Biochem Soc Trans. 1993;21:569-582.
20. Jukema JW, Vanboven AJ, Groenemeijer B, Zwinderman AH, Reiber JHC, Bruschke AVG, Henneman JA, Molhoek GP, Bruin T, Jansen H, Gagne E, Hayden MR, Kastelein JJP. The Asp(9)Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation. 1996;94: 1913-1918.
21. Mailly F, Fisher RM, Nicaud V, Luong L-A, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis. 1996; 122:21-28.
22. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta. 1996;130:159-166.
23. Ailhaud G. Cellular and secreted lipoprotein lipase revisited. Clin Biochem. 1990;23:343-347.
24. Laskarzewski PM, Morrison JA, Mellies MJ, Kelly K, Gartside PS, Khoury P, Glueck CJ. Relationships of measurements of body mass to plasma lipoproteins in school children and adults. Am J Epidemiol. 1980;111:395-407.
25. Jemaa R, Fumeron F, Poirer O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou J-P, Bard J-M, Fruchart JC, Apfelbaum M, Cambien F, Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res. 1995;36:2141-2146.
26. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. Inverse relationship between blood levels of high density lipoprotein sub-fraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA. 1983;30:1449-1453.
27. Sprecher DL, Knauer SL, Black DM, Kaplan LA, Akeson AA, Dusing M, Lattier D, Stein EA, Rymaszewski M, Wiginton DA. Chylomicron-retinyl palmitatc clearance in type I hyperlipidemic families. J Clin Invest. 1991;88:985-994.
28. Micsenböck G, Holzl B, Foger B, Brandstatter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91:448-455.
29. Humphries S, Fisher R, Mailly F, Peacock R, Talmud P, Karpe F, Hamsten A, Miller GJ. Gene-environment interaction in determining plasma lipids and dietary response: the effects of common mutations in the gene for lipoprotein lipase (D9N and N291S). In: Bray GA, Ryan DH, eds. Pennington Center Nutrition Series: Vol 6. Nutrition, Genetics and Heart Disease. Baton Rouge. La/London. UK: Louisiana State University Press; 1996:279-295.
30. Wilson DE, Emi M, Iverius PH, Hata A, Wu LL, Hulas E, Williams RR, Lalouel JM. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest. 1990;86: 735-750.
31. Bijvoet S, Gagne SE, Moorjani S, Gagne C, Henderson HE, Fruchart JC, Dallongeville J, Alaupovic P, Prins M, Kastelein JJP, Hayden MR. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res. 1996;37:640-650.